Literature DB >> 8201832

Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases.

J Mezger, A Calavrezos, P Drings, U Gatzemeier, E Kaukel, N Konietzko, G Koschel, R Lamerz, J von Pawel, W Römer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8201832     DOI： 10.1007/bf00175946

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  8 in total

1.  Diagnosis of diffuse malignant mesothelioma: experience of a US/Canadian Mesothelioma Panel.

Authors:  W T McCaughey; T V Colby; H Battifora; A Churg; J M Corson; S D Greenberg; M M Grimes; S Hammar; V L Roggli; K K Unni
Journal:  Mod Pathol       Date:  1991-05       Impact factor: 7.842

Review 2.  Malignant mesothelioma of the pleura.

Authors:  R J Pisani; T V Colby; D E Williams
Journal:  Mayo Clin Proc       Date:  1988-12       Impact factor: 7.616

3.  Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.

Authors:  J Mezger; R Lamerz; W Permanetter
Journal:  J Thorac Cardiovasc Surg       Date:  1990-12       Impact factor: 5.209

Review 4.  Carcinoembryonic antigen in pleural effusions. Diagnostic value in malignant mesothelioma.

Authors:  B Faravelli; E D'Amore; M Nosenzo; P G Betta; A Donna
Journal:  Cancer       Date:  1984-03-01       Impact factor: 6.860

5.  New strategies are needed in diffuse malignant mesothelioma.

Authors:  K S Sridhar; R Doria; W A Raub; R J Thurer; M Saldana
Journal:  Cancer       Date:  1992-12-15       Impact factor: 6.860

6.  Tumour associated antigens in diagnosis of serous effusions.

Authors:  J Mezger; W Permanetter; A L Gerbes; W Wilmanns; R Lamerz
Journal:  J Clin Pathol       Date:  1988-06       Impact factor: 3.411

7.  Detection of malignant pleural effusions by tumor marker evaluation.

Authors:  F Pavesi; M Lotzniker; P Cremaschi; L Marbello; L Acquistapace; R Moratti
Journal:  Eur J Cancer Clin Oncol       Date:  1988-06

8.  [Carcinoembryonic antigen in serum and pleural fluid to distinguish between bronchial carcinoma and pleural mesothelioma].

Authors:  J Mezger; R Lamerz; M Bresgen; A Schulz; K H Berghäuser; F Liewald; L Sunder-Plassmann; K Häussinger; W Wilmanns
Journal:  Dtsch Med Wochenschr       Date:  1991-02-08       Impact factor: 0.628
  8 in total
  4 in total

1.  Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma.

Authors:  Jenette Creaney; Deborah Yeoman; Leanne K Naumoff; Michelle Hof; Amanda Segal; Arthur William Musk; Nicholas De Klerk; Nora Horick; Steven J Skates; Bruce W S Robinson
Journal:  Thorax       Date:  2007-03-13       Impact factor: 9.139

2.  Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients.

Authors:  Sied Mohammad Ali Ghayumi; Samrad Mehrabi; Mehrnossh Doroudchi; Abbas Ghaderi
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

3.  Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.

Authors:  M Miédougé; P Rouzaud; G Salama; M C Pujazon; C Vincent; M A Mauduyt; J Reyre; P Carles; G Serre
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

4.  Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion.

Authors:  Klaus Hackner; Peter Errhalt; Sabin Handzhiev
Journal:  Ther Adv Med Oncol       Date:  2019-05-22       Impact factor: 8.168
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.